冠心病患者PCI治疗后发生造影剂肾病的危险因素分析

摘要/Abstract

摘要： 目的探讨冠心病患者行PCI术后发生造影剂肾病（CIN）的危险因素。方法以2015年5月至2018年4月我院收治的269例冠心病患者作为研究对象,所有患者均行冠脉造影检查及PCI治疗,收集患者基础资料、生化、手术等相关信息,依据是否发生CIN,分位CIN组（46例）和非CIN组（223例）,分析造影剂肾病的危险因素。结果 CIN组年龄更大,合并糖尿病患者更多。CIN组血糖、尿酸、同型半胱氨酸、术后48h肌酐、造影剂用量更高。多因素Logistic回归分析提示年龄、糖尿病、尿酸、同型半胱氨酸、造影剂用量是影响CIN发生的独立危险因素。结论患者合并高尿酸血症、高同型半胱氨酸血症是发生CIN的高危人群,尿酸及同型半胱氨酸水平是CIN发生的独立危险因素。

关键词: 经皮冠状动脉介入治疗, 造影剂肾病, 冠心病, 危险因素

张建铭. 冠心病患者PCI治疗后发生造影剂肾病的危险因素分析[J]. 心血管病防治知识, 2019, 9(20): 22-24.

参考文献

[1] Mauro M,Mdanna T,Mdario Leon-Cini MD,et al.Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patents with renal dysfunction undergoing coronary angiography or intervention.[J] AM Coll Cardiol,2008,52:599-604.
[2] Mehran R,Aymong E D,Nikolsky E ,eta1.A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention : development and initial validation[J]. J A m Cardiol,2004,44(7):1393-1399.
[3] SenooL Motohiro M,Kamihata H,et a1.Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome[J].Am J Cardiol,2010,105(5):624-628.
[4] Levy EM,Viscoli CM,Horwitz RI.The effect of acute renal failure on mortality. A cohort analysis[J]. JAMA,1996,275(19):1489-94.
[5] Steven F,John D,Kevin M,et al.N-Acetylcystcin in the prevention of radiontrast-induce nephropathy[J] Am Soc Nephrol,2004,15:251-260.
[6] 陈雯,王海燕.急性肾衰竭.[J]英国医学杂志,2003,6:174-183.
[7] 贾万明, 牛素贞. 血尿酸对冠心病合并糖尿病患者造影剂肾病发生率的影响[J].中国动脉硬化杂志 2018 ,26(5 ),503-506
[8] Elbasan ZS,Ahjll DY, Gnr M,et a1.Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention[J].Angiology,2014,65(1):37-42.
[9] Filiopoulus V、Hadjiyannakos D,Vlassoppulos D.New insights into uric acid effects on the progression and prognosis of chronic kidney disease [J].Ren Fail,2012,34(4):5lo-520.
[10] Sautin YY,Nakagawa T,Zharikov S,eta1.Adverse effects of the classic antioxidant uric acid in adipocytes:NADPH oxidase-mediated oxidative/nitrosative stress[J].Am J Physiol cell Physiol,2007,293(2):C584-596
[11] Kanbay M,YiImaz MI,Sonmez A,et a1.Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease[J].Am J Nephrol,2011,33(4):298-304
[12] Nakagawa T, Kang DH, Feig D, et al.Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease[J].Kidney Int,2006,69( 10) : 1722-725.
[13] 许豪,张金盈. 冠心病合并高同型半胱氨酸血症与造影剂肾病的相关性研究[J]. 河南医学研究,2016,25(12):2135-2137
[14] 雷明明,颜冰,张壬,等. 同型半胱氨酸在早期预测造影剂肾病中的作用和意义[J]. 中国医师杂志,2015,17(1):89-91.
[15] Kiln S J, Choi D,Ko Y G, eta1. Relation of homocysteinemiato contrast induced nephropathy in patients undergoing percutaneous coronary intervention[J].AMJ Cardiol, 2011,108(8):1086-1091.
[16] Erol T,Tekin A,Katircibasi M T,et a1.Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy:a randomized controlled trail.[J].IntJ Cardiol,2013,167(4):1396-1399.